Derrell Peel Weighs in on Beta Agonists and Market ImpactsThu, 08 Aug 2013 09:04:09 CDT
There have been market impacts internationally for feedlot cattle that are fed Ractopamine- and Extension Livestock Market Economist Dr. Derrell Peel says that the industry will have to weigh the value of the product and its ability to convert lean muscle from body fat in the final days of feeding for cattle being readied for market.
Several major importers of beef and pork have import bans of meat from animals fed with Ractopamine- marketed in the US by Elanco under the trade name Optaflexx.
Besides the bans in other countries- there is at least one market worry domestically with the feeding of beta- agonists- which includes both ractopamine as well as zilpaterol (marketed as Zilmax). That concern, according to Dr. Peel, is the unintended consequence of these products helping dry up the live cash cattle market- especially in the southern Great Plains.
After recording our conversation with Dr. Peel- another problem that has surfaced is the decision by Tyson Foods, the nation's largest beef packer, to halt purchases of cattle fed with Zilmax because of lameness in cattle coming into their processing plants. Click here for a report from Reuters on the planned purchase stoppage.
You can also read a industry developed Fact Sheet about beta- agonists by clicking here.
And- there is a letter referenced in the Reuters article that Tyson has sent to the feedlots that they buy cattle from- it can be seen by clicking on the PDF file link at the bottom of this story.
Dr. Peel is our guest on today's Beef Buzz.
The Beef Buzz is a regular feature heard on radio stations around the region on the Radio Oklahoma Network- but is also a regular audio feature found on this website as well. Click on the LISTEN BAR below for today's show- and check out our archives for older Beef Buzz shows covering the gamut of the beef cattle industry today
TysonCattle Feeders Notice 8-13.pdf
WebReadyTM Powered by WireReady® NSI
Top Agricultural News